Pancreatic cancer overview: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
'''Pancreatic cancer''' is a [[cancer|malignant tumour]] within the [[pancreas|pancreatic gland]]. | '''Pancreatic cancer''' is a [[cancer|malignant tumour]] within the [[pancreas|pancreatic gland]]. | ||
About 95 percent of pancreatic tumors are [[adenocarcinoma]]s ({{ICDO|8140|3}}). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic [[neuroendocrine tumor]]s (such as [[insulinoma]]s, {{ICDO|8150|1}}, {{ICDO|8150|3}}). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.<ref name=Ghaneh/> | About 95 percent of pancreatic tumors are [[adenocarcinoma]]s ({{ICDO|8140|3}}). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic [[neuroendocrine tumor]]s (such as [[insulinoma]]s, {{ICDO|8150|1}}, {{ICDO|8150|3}}). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.<ref name=Ghaneh/> | ||
Revision as of 17:08, 28 August 2012
|
Pancreatic cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic cancer overview On the Web |
|
American Roentgen Ray Society Images of Pancreatic cancer overview |
|
Risk calculators and risk factors for Pancreatic cancer overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Pancreatic cancer is a malignant tumour within the pancreatic gland.
About 95 percent of pancreatic tumors are adenocarcinomas (Template:ICDO). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic neuroendocrine tumors (such as insulinomas, Template:ICDO, Template:ICDO). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.[1]
References
- ↑ Invalid
<ref>tag; no text was provided for refs namedGhaneh